New hope for kids with severe eczema: 2-Year dupilumab study shows promise
NCT ID NCT05983068
First seen Apr 19, 2026 · Last updated May 19, 2026 · Updated 6 times
Summary
This study looks at how well dupilumab (Dupixent) works over 2 years in children aged 6 to 14 with moderate-to-severe atopic dermatitis (eczema). About 48 kids will receive the drug and researchers will measure skin barrier function and track side effects. The goal is to see if long-term treatment helps control the disease and improves skin health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS, ATOPIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site Number : 8260001
Sheffield, S10 2TH, United Kingdom
-
NYU Langone Medical Center- Site Number : 8400004
New York, New York, 10016, United States
-
National Jewish Health Medical Center- Site Number : 8400001
Denver, Colorado, 80206, United States
-
SSM Health Saint Louis University Hospital- Site Number : 8400006
St Louis, Missouri, 63104, United States
Conditions
Explore the condition pages connected to this study.